EMILY MARSHALL: Open Payments
NPI 1811285307 · LAFAYETTE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 57 payments from 14 companies in 2025. Trend: 2023 $2,043 · 2024 $961 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $374 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $218 |
| Janssen Biotech, Inc. | 6 | $169 |
| PFIZER INC. | 4 | $165 |
| GENZYME CORPORATION | 1 | $148 |
| Madrigal Pharmaceuticals | 3 | $97 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Mirum Pharmaceuticals, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
Products named: ENTYVIO, SKYRIZI, TREMFYA, VELSIPITY, REZDIFFRA, RINVOQ, DUPIXENT, Livmarli.
Industry payments across CO — which companies pay providers there.
